Stepan Q1 2024 Earnings Call Transcript

Quartr
Provided by Quartr
April 30, 2024

There are 6 speakers on the call.

Operator

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Luis Rojo, CFO.

Operator

Please go ahead.

Speaker 1

Good morning, and thank you for joining Stepan Company's Q1 2024 Financial Review. Before we begin, please note that information in this conference call contains forward looking statements, which are not historical facts. These statements involve risks and uncertainties that could cause actual results to differ materially, including, but not limited to, prospects for foreign operations, global and regional economic conditions and factors detailed in our Securities and Exchange Commission filings. In addition, this conference call will include discussion of adjusted net income, adjusted EBITDAR and free cash flow, which are non GAAP measures. We provide reconciliations to the comparable GAAP measures in the earnings presentation and press release, which we have made available at www.stepan.com under the Investors section of our website.

Speaker 1

Whether you're joining us online and over the phone, we encourage you to review the investor slide presentation. We make these slides available at approximately the same time as well as the earnings release is issued, and we hope that you find the informational perspective helpful. With that, I would like to turn the call over to Mr. Scott Benz, our President and Chief Executive Officer.

Speaker 2

Good morning, and thank you all for joining us today to discuss our Q1 2024 results. I plan to share highlights from our Q1 performance and will also share updates on our key strategic priorities, while Luis will provide additional details on our financial results. The company reported 1st quarter adjusted EBITDA of $51,200,000 up 5% year over year. Global sales volume was up 1% year over year. Volume weakness in the agricultural market due to continued inventory destocking and lower phthalic anhydride volumes due to ongoing operational issues at our Milldale site mostly offset the strong recovery in volumes across our other core markets.

Speaker 2

Global sales volume excluding the impact of agricultural and PA was up 4%. Surfactants experienced double digit volume growth in personal care and oilfield end markets and with our distribution partners. As expected, Latin American Surfactant volumes grew strong double digits as we recovered volumes in Mexico. 1st quarter sales volume in Mexico was a record. Overall, volumes in our global consumer laundry and cleaning and our institutional cleaning businesses have stabilized and we believe destocking has run its course.

Speaker 2

Within polymers, rigid and specialty polyols grew mid single digits, while specialty products volume was up double digits. From a company perspective, margins were in line with expectations despite unfavorable product mix. Net sales in the Q1 of 2024 decreased 15% year over year, primarily due to lower selling prices that were mainly attributable to the pass through of lower raw material costs and less favorable product mix. These lower selling prices were partially offset by a 1% increase in global sales volume as mentioned above and the favorable impact of foreign currency translation. We generated positive free cash flow of $11,400,000 as capital expenditures returned to historical levels and these results give us confidence that we will close 2024 with positive free cash flow.

Speaker 2

The company is on track to deliver our $50,000,000 cost reduction goal for 2024 through disciplined efforts in supply chain and workforce productivity actions taken in the last quarter of 2023. We expect these reductions to help offset higher operating costs related to operational interruptions at our mill sale site and pre commissioning expenses at our new alkoxylation facility in Pasadena, Texas. During the Q1 of 2024, the company paid $8,500,000,000 in dividends to shareholders. The company did not repurchase any company stock during the 1st 3 months of 2024 and has $125,000,000 remaining under the share repurchase program authorized by our Board of Directors. Yesterday, our Board of Directors declared a quarterly cash dividend on Stepan's common stock of 0.375 dollars per share payable on June 14, 2024.

Speaker 2

Stepan has paid and increased its dividend for 56 consecutive years. With the volume performance in several of our end markets delivering strong growth, we remain confident in the strength and diversity of our business and its ability to generate cash that will allow us to continue to invest in our business and return cash to our shareholders. Luis will now share some details about our Q1 results.

Speaker 1

Thank you, Scott. My comments will generally follow the slide presentation. Slide 5 shows the total company net income bridge for the Q1 compared to last year Q1 and breakdown the decrease in adjusted net income. Because this is net income, the figure is not here on an after tax basis. First quarter 2024 adjusted net income was $14,700,000 or $0.64 per diluted share versus $16,400,000 or $0.71 per diluted share for the Q1 of last year.

Speaker 1

The adjusted net income reduction was driven by a higher effective tax rate compared to 2023. We are projecting a higher effective tax rate for 2024 due to the anticipated disallowance of the GILTI reduction and foreign tax credit, resulting from the expected election of bonus depreciation for our Pasadena capital investments. Slide 6 shows the total company adjusted EBITDA bridge for the Q1 compared to last year Q1. Adjusted EBITDA was $51,200,000 versus $48,700,000 in the prior year, a 5% increase year over year. We will cover each segment in more detail, but to summarize, we delivered adjusted EBITDA growth in Surfactants and Specialty Products, partially offset by Global Polymers.

Speaker 1

Lower corporate expenses also contributed to the adjusted EBITDA growth. Slide 7 focuses on Surfactant segment results. Surfactant net sales were $391,000,000 for the quarter, a 16% decrease versus the prior year. Selling prices were down 18%, primarily due to the pass through of lower raw material costs, less favorable product mix and competitive pricing pressures in Latin America and Europe. Volume was flat year over year.

Speaker 1

We delivered a strong double digit growth in Personal Care from our low-one-four thousand investments and in the oilfield end market. We also grew volume in the Construction and Industrial Solutions business and with our distribution partners. Latin America Surfactants volume also grew a strong double digit as we continue recovering the business. This growth was offset by lower demand within the agricultural end market due to continued customer and channel inventory destocking. Foreign currency translation positively impacted net sales by 2%.

Speaker 1

The fact that adjusted EBITDA for the quarter increased $1,500,000 or 4% versus the prior year. Engage was driven by the margin improvement that was partially offset by pre operating expenses at the company's new Acox Collection facility being built in Pasadena, Texas and expenses associated with operational interruptions at the Millfield plant site. Excluding these one time expenses, adjusted EBITDA grew double digits in the Surfactant business. Now on Slide 8, Polymer net sales were $146,000,000 for the quarter, a 10% decrease versus the prior year. Selling price decreased 14%, primarily due to the pass through of lower raw material costs.

Speaker 1

Volume increased 1% in the quarter, driven by a 4% increase in global rigid polyols and 7% increase in specialty volumes. This excellent volume growth was partially offset by lower PA volumes due to the millshell operational interruption. Rigid Polyol experienced growth in all regions. Foreign currency translation positively impacted net sales by 3%. Polymer adjusted EBITDA decreased $1,900,000 or 10%, primarily due to the previous communicated higher expenses due to the mill sale operational issue.

Speaker 1

Excluding this one time expenses, adjusted EBITDA grew in the polymers business. Finally, specialty product net sales were $15,000,000 for the quarter, a 33% decrease versus the prior year. Volume was up BB versus the prior year, while adjusted EBITDA increased $1,900,000 or 49%. The increase in adjusted EBITDA was primarily due to both higher unit margins and volume within the MCT product line. Turning to Slide 9, we continue making progress on our cash position.

Speaker 1

For the Q1, cash from operation was $42,000,000 and free cash flow was positive at $11,400,000 up $176,000,000 versus 2023. We continue optimizing our inventory levels and we were able to reduce another $8,000,000 During the quarter, we deployed $38,000,000 against CapEx investments and dividends.

Speaker 2

Now on Slide 10 11, Scott will update you on our strategic priorities and capital investments. Thanks, Luis. I'll focus my comments on our cost initiatives, business strategy and the progress of our major capital investments. The cost reduction program initiated last year along with additional productivity and cost out initiatives underway in 2024 centered around improved operational performance across our supply chain network are expected to deliver $50,000,000 in pre tax savings in 2024. As of the Q1, the company was on track to deliver its $50,000,000 cost out goal and recognized $18,000,000 in pretax savings.

Speaker 2

This was largely offset by the incremental expenses related to the Millsdale operational issue, commissioning expenses in our new Pasadena site, higher operating expenses related to the new low-fourteen Dioxane manufacturing process and overall labor cost inflation. We are encouraged by the volume performance in several of our end markets delivering growth. Surfactant's delivered strong volume growth in personal care, oilfield, construction and industrial solution end markets and with our distribution partners. Latin American Surfactants delivered strong double digit growth with record volumes Mexico. Rigid and Specialty Polyols volume grew 4% and 7% respectively, while specialty products volume was up double digits.

Speaker 2

Our large laundry and cleaning consumer and institutional cleaning businesses have stabilized and we expect gradual and modest growth in the future. Our customers will always remain at the center of our strategy and innovation. Our long standing Tier 1 customers value our technical capacity and the ability to manufacture and deliver quality products at the scale they need. We continue to diversify our customer base by expanding our reach to Tier 2 and Tier 3 customers who highly value the technical support and services StepN can provide. During the Q1 of 2024, we added approximately 400 new Tier 2 and Tier 3 customers, increasing the segment volumes versus the prior year.

Speaker 2

Our technical collaborations are increasingly focused on helping our customers make their product portfolio transition towards a more sustainable future and we are happy to be on this journey with them. Our diversification strategy in Tier 2 and Tier 3 markets and functional markets, including agricultural and oilfield chemicals continues to be a key priority for STEPN. Insulation remains a critical enabler of a more sustainable and energy efficient world. Our polymers business continues to focus on developing the next generation rigid polyol technologies that can increase the energy efficiency and cost performance of our customers' insulation products. Moving to Slide 11, construction at our new alkoxylation production facility in Pasadena, Texas is approximately 90% complete and we now expect the plant to start up in the Q4 of 2024 due to a contractor delay.

Speaker 2

The underlying alkoxylation business that supports the Pasadena investment excluding the agricultural destocking continued its volume growth during the Q1 of 2024 at very attractive unit margins. After completing a 3 year capital investment program last year, STEPN now has the largest installed low 14 Doxane production capacity serving the North American merchant market. Our first quarter volumes grew strong double digits versus prior year and volume should continue to ramp throughout the year as more customer and product qualifications are completed. As already reported in our February earnings call, our Millsdale site was impacted by a series of power disruptions combined with below freezing temperatures in January was the main impact to the phthalic anhydride and polyol unit operations. All operations other than phthalic anhydride have been in our back end production and we were able to minimize supply disruptions to our polyol customers through our production network.

Speaker 2

The PA unit experienced several restart challenges, but has since been restarted and is producing product. In addition to the power weather interruption, we also experienced unplanned maintenance and operational issues with the Millsdale Wastewater Treatment Plant. Our team has been actively addressing these issues through infrastructure and process improvements. These operational issues impacted 1st quarter results primarily from higher maintenance and operational expense and higher tolling costs. We anticipate 2nd quarter expenses related to these issues to be similar to the 1st quarter expenses.

Speaker 2

We anticipate to go back to normal and lower spending levels in the second half of the year. Looking forward, we believe sales volumes will continue to gradually improve due to the ongoing recovery in rigid polyols and growth in surfactant volumes, including the expected recovery of the agricultural business in the second half of this year. We remain focused on delivering $50,000,000 in pre tax cost reductions to help offset inflationary pressures, the expenses associated with commissioning our New Pasadena alkoxylation assets, higher incentive based compensation and incremental expenses associated with the operational issues at Millersdale. Free cash flow should continue to improve versus prior year as we finish construction on our Pasadena investment agricultural volumes in the second half of the year. Continued gradual growth in market volumes, improved operational performance and our continued focus on cost reduction should position us to deliver full year adjusted EBITDA growth and positive free cash flow.

Speaker 2

We remain confident in our long term growth and innovation initiatives. This concludes our prepared remarks. At this time, we would like to turn the call over for questions. Didi, please review the instructions for the question portion of today's call. Thank

Operator

And our first question comes from Vincent Anderson of Stifel. Your line is open.

Speaker 3

Yes. Good morning, gentlemen. Thanks. Good morning, Vincent. Apologies in advance if you've answered any of this.

Speaker 3

You guys are moving a little bit faster than I am today. But I wanted to start with the operating income in Surfactants because it sounds like there was a lot of little issues here in the quarter, but the margins came in quite strong regardless. So can you maybe just talk about what the big positives were, whether it was all fixed cost leverage or raw materials? And then kind of second to that, are there Tier 2, Tier 3 and oilfield gains, have those been enough to offset the mix headwinds from agriculture?

Speaker 1

Hi, Vincent. This is Luis. Look, as we said in our prepared remarks, adjusted EBITDA for Surfactant was slightly up 4% versus last year. And actually, if you exclude the one time expenses that we had because of the disruption in New Zealand, our adjusted EBITDA in Surfactant is actually up double digits, which is a good testament of margin improvement. So you saw volumes flat in Surfactors, overall flat with several places growing double digits.

Speaker 1

But overall volume is flat, so the driver of the adjusted EBITDA growth is margin despite the fact that AG is a significant negative mix in the numbers. If you exclude the AG destocking, our operating income and our adjusted EBITDA in this business will be up very, very strong double digits. So ag is a negative impact.

Speaker 3

Okay. All right. Perfect. Thank you. And then, so I don't I'm not sure exactly how to ask this one, but I appreciate that Millsdale is a very large complex plant.

Speaker 3

It's one of your older plants. I just I'm trying to understand what opportunities there are maybe within your kind of scheduled turnarounds that you would have an opportunity to really go deep into that plant and try to tie up some of these loose ends that seem to crop up. It feels like every year at this point, whether it's power or now wastewater. I'm just trying to kind of understand where that plant is in that kind of cycle of shorter term maintenance needs and maybe longer term projects that you haven't had an opportunity to address?

Speaker 2

Yes, great question, Vincent. First of all, we do have a long term infrastructure reinvestment plan for that site. And we do follow and execute against that every year. The power disruptions that seem to be more frequent over the last 3 or 4 years, That's a real issue that we're working on with our external power providers. As you know, in this country, the energy infrastructure is aging and there is more reinvestment.

Speaker 2

So our primary focus is to improve the quality and reliability of the power that we get into our Millsdale site. And that's actively being worked on. With regards to our other maintenance outage. We do turnarounds on all of our infrastructure assets. This one kind of creeped up unexpectedly.

Speaker 2

We're managing it and should be rectified here in the Q2. So it is one of our older sites in our global network. It is very large and it's a main focus for us to continue to improve and then reinvest for improved reliability for our customers.

Speaker 3

All right. That's excellent. Thank you. And just one last one. I'm just trying to get a feel for do your polyol volumes or at the very least your demand indications given some of the disruptions this quarter.

Speaker 3

Do you feel like they're tracking what you're seeing your customers put out there in terms of insulation volumes? Or is there maybe still a little bit of a disconnect in terms of how they're managing inventory or timing of these projects?

Speaker 2

I think directionally the answer is yes. I think some of the customers that may have reported earlier, Some of their growth may be a little disconnected from ours due to things that they're doing in the with their marketing programs. But overall, I think we're pleased that our volume is tracking. It's on a recovery path. There seems to be a lot of pent up demand for reroofing projects.

Speaker 2

And I think if we can clear some of the operational issues we have, you'll see our numbers track more closely to what you may be expecting from the customer base release.

Speaker 1

And the growth in polymers was broad based with all the regions growing and also specialty polyols growing plus 7%, which is pretty strong.

Speaker 3

Excellent. All right. Thanks. That's all from me guys.

Operator

Thank you. One moment for our next question. And our next question

Speaker 2

Good morning, Mike.

Speaker 4

Apologies if I missed this, but did you quantify the impact of the Millsdale outage in Q1 overall? And how that was split between the Polymers and Surfactant segments?

Speaker 1

Yes. I remember in February, we said we were expecting around $5,000,000 of pretax income. We included in the release. I know it's early. We included the exact numbers $5,800,000 was the impact and call it half and half between the businesses.

Speaker 1

And as Scott put in his remark, we're expecting kind of the same in Q2.

Speaker 4

All right. Thank you for that. And then I was also curious just on the price mix number that minus 18 percent was quite a bit weaker than we were anticipating. I guess what I'm trying to understand is when do you expect those price mix headwinds to stabilize? Maybe how much of that 18% decline was price?

Speaker 4

How much was mix? And related to that, if you are expecting ag demand to pick back up and destocking to run its course in that ag business in the second half, how much does mix recovery from ag help that price mix number as we get into the second half?

Speaker 1

Yes. No, great question, Mike. As you said, 18%, of course, the majority of that is pricing and ag is still a big negative mix impact into that number. But you saw our cost of goods sold also down $100,000,000 despite the increases in overhead. So raw material prices are going down significantly, more so on a percentage basis that the price reduction that you saw.

Speaker 1

So that's how we are improving margins in the 3 businesses when you look at dollars per pound.

Speaker 2

Pound. And Mike, I'll add, we're coming off a record 2023 first quarter ag business. So that price mix is definitely impacted this year from the ag destocking. And yes, it will be a significant improvement in the second half when the ag recovery restarts.

Speaker 4

And I guess just to follow-up on that, can you give a little bit of color on what your customers in the Ag business are saying right now? I'm just trying to get a better sense of what gives you confidence or how confident you are that those volumes are going to start to pick up in the ag business in the second half?

Speaker 2

Yes. Mike, I'd say from a customer perspective, it's a little bit of a mixed bag, whether it will start in Q3 or Q4. But what we have to remember is the world's demand for food and protein will always remain. So this inventory, once it gets through the destocking phase, the demand at the farmer level is still there. So I think it's a matter of when not if.

Speaker 2

And I'd say right now there's probably a fifty-fifty mix at Q3 versus Q4.

Speaker 4

All right. And then last question for me is just in terms of the outlook, you're pointing to adjusted EBITDA growth versus last year. Obviously, last year was unusually weak. But looking at where you were in the Q1, this $51,000,000 EBITDA number and presumably would have been $6,000,000 higher without the Millsdale outage, Should we be modeling improvement from that level in Q2 and then further improvement in Q3 as we get past the Millsdale issues? I guess just any additional color you're willing to provide on the earnings cadence from here, I think would be helpful given there are a lot of moving pieces in place?

Speaker 1

Yes, Mike. And you know that we don't provide formal guidance for the quarter or for the year, but and that's why we are trying to provide some perspective on the expenses that we foresee in Q2. So you can model that in your second quarter. And then of course, we all expect some improvement in the second half because of the ag recovery. I mean, we cannot hide that.

Speaker 1

Mean, we're saying we are expecting the recovery of ag and ag is a good business for us and of course should have a positive impact in our EBITDA in the second half versus the first half.

Speaker 4

All right. That's helpful. Thank you.

Operator

Thank you. One moment for our next question. And our next question comes from Dave Storms of Stonegate. Your line is open.

Speaker 5

Good morning.

Speaker 1

Good morning, Dave. Good morning.

Speaker 5

Just if we could touch on Latin America for a second, great to see volumes coming up there. Can we expect pricing to follow or is there still more focus on defending and capturing market share there?

Speaker 2

Yes, great question. Yes, Dave, our priority was to recover the volumes. If you remember, we talked about competitive imports in the prior quarters. Our goal is to recover the share. So that remains our priority.

Speaker 2

There's hope over time that pricing will improve, but right now it's reestablishing the beachhead.

Speaker 5

Understood. Very helpful. And then just one more for me. On the customer acquisition environment, great to see that you picked up some more Tier 2 and Tier 3 customers. What is the contact to contract cycle looking like there?

Speaker 5

Is that improving? And how does that compare to trying to pick up obviously more Tier 1 customers as well?

Speaker 2

The Tier 2, Tier 3 customers, those tend to be the smaller customers around the world from a contracted basis. It's really not contracted business. It's more transactional type of relationships. But I think where we differentiate ourselves is the technical service. So when we help these customers put new formulations on the shelf, there is a sense of loyalty.

Speaker 2

But there's nothing that you can put under a contract umbrella saying that that's a fully stabilized business. But we had record volumes in Q1 within that customer segment, which we're pretty pleased with those results.

Speaker 5

Understood. Thank you for taking my questions and good luck in Q2. Thanks.

Operator

Thank you. At this time, I'd like to turn it back to Scott Burns for closing remarks.

Speaker 2

Thank you very much for joining us on today's call. We appreciate your interest and ownership in Stepan Company, and please have a great day.

Powered by Quartr

Key Takeaways

  • Stepan reported Q1 adjusted EBITDA of $51.2 million, up 5% year-over-year, driven by volume growth in surfactants and specialty products despite agricultural destocking and operational disruptions at the Milldale site.
  • Net sales decreased 15% as lower raw-material-linked selling prices and an unfavorable product mix offset a 1% rise in global volume (4% ex-agriculture and PA), with foreign currency translation adding about 2%.
  • Free cash flow was positive $11.4 million for the quarter, and the company remains on track to achieve its $50 million cost-reduction target through disciplined supply-chain and workforce productivity initiatives.
  • The Surfactants segment saw double-digit volume growth in personal care, oilfield and Latin American markets (with record volumes in Mexico) and, excluding one-time expenses, delivered robust double-digit adjusted EBITDA gains.
  • Construction of the Pasadena alkoxylation facility is ~90% complete with startup now expected in Q4 2024, and with agricultural volumes poised to recover in H2, Stepan anticipates full-year EBITDA growth and continued free cash flow improvement.
AI Generated. May Contain Errors.
Earnings Conference Call
Stepan Q1 2024
00:00 / 00:00